Patents
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
07/2009
07/14/2009US7560552 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
07/14/2009US7560546 Tyrosine kinase inhibitors
07/09/2009WO2009085185A1 Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors
07/09/2009WO2009084501A1 Sultam derivative
07/09/2009US20090176779 Pyrazolo[4,3-d]thiazole derivatives, and preparation and therapeutic application thereof
07/09/2009US20090176307 Compounds, Compositions and Methods
07/09/2009CA2709202A1 Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors
07/08/2009EP2076518A1 Tricyclic spiro-oxindole derivatives and their uses as therapeutic agents
07/08/2009EP2076512A1 Fused thiazole derivatives as kinase inhibitors
07/08/2009EP2076132A1 P-toluene sulfonic acid salt of 5-amino-3-(2'-o-acetyl-3'-deoxy-beta -d-ribofuranosyl)-3h-thiazole [4, 5-d]pyrimidine-2-one and methods for preparation
07/08/2009EP1073647B1 12,13-cyclopropane epothilone derivatives
07/08/2009CN101479238A Amine derivative having npyy5 receptor antagonist activity
07/07/2009US7557120 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity
07/07/2009US7557114 Heterocyclic-substituted phenyl methanones
07/02/2009WO2009081460A1 Spirooxazine radical derivatives and reversible isomerization reaction
07/02/2009WO2009080836A2 Macrocyclic indoles as hepatitis c virus inhibitors
07/02/2009WO2009079767A1 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer
07/02/2009WO2009037001A4 Novel tetrahydrofusedpyridines as histone deacetylase inhibitors
07/02/2009WO2009013545A3 Chemical compounds
07/02/2009WO2009010925A3 Annelated azaheterocyclic amides containing a pyrimidine fragment and method for the production and use thereof
07/02/2009US20090170830 Tricyclic Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
07/02/2009US20090170172 Recombinant Methods and Materials for Producing Epothilone and Epothilone Derivatives
07/02/2009US20090169558 Bicyclic aromatic compounds useful as inhibitors of mitogen-activated protein kinase-activated protein kinase-2
07/02/2009CA2710644A1 Macrocyclic indoles as hepatitis c virus inhibitors
07/02/2009CA2709536A1 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer
07/01/2009EP2074089A2 Organic compounds
06/2009
06/25/2009WO2009040730A3 Pyrrolidines and piperidines as orexin receptor antagonists
06/25/2009WO2008046084A3 Spiroheterocyclic compounds and their uses as therapeutic agents
06/25/2009US20090163547 Indene derivatives, their preparation and use as medicaments
06/25/2009US20090163542 5-ht7 receptor antagonists
06/24/2009EP1863812A4 Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
06/24/2009CN101466717A Thiazolyldihydroindazoles
06/23/2009USRE40793 treating conditions related to impairment of gastric emptying, gastromotility disorders; superior gastrokinetic properties; e.g. trans-4-amino-N-[(1-butyl-3-hydroxy-4-piperidinyl)methyl]-5-chloro-2,3-dihydro-7-benzofurancarboxamide
06/23/2009US7550588 Homotropanes with central nervous system activity
06/23/2009US7550489 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide and phentermine, metformin, or bupropion; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
06/18/2009WO2009076337A1 Gamma secretase modulators
06/18/2009WO2009074812A1 Antibacterial condensed thiazoles
06/18/2009WO2009074810A1 Antibacterial compositions
06/18/2009US20090156827 Material for organic electroluminescent elements and organic electroluminescent element
06/18/2009US20090156554 N-[1-(3-dimethylamino-4-formyl-phenyl)-3-pyridin-3-yl-4,5-dihydro-1H-pyrazolo[4,3-g]benzothiazol-7-yl]-acetamide; phosphatidylinositol-3-kinases (PI3-kinases) inhibitor; cell growth, differentiation and intracellular transport processes; antiproliferative, antiinflammatory agent; autoimmune diseases
06/18/2009US20090152538 Thiazole-based semiconductor compound and organic thin film transistor using the same
06/18/2009CA2709021A1 Antibacterial condensed thiazoles
06/18/2009CA2708151A1 Gamma secretase modulators
06/17/2009EP2069365A1 Novel 5,7-disubstituted [1, 3]thiazolo [4, 5d]pyrimidin-2 (3h)-amine derivatives and their use in therapy
06/17/2009EP2069364A1 Novel 5, 7-disubstituted [1, 3]thiazolo [4, 5-d]pyrimidin-2 (3h)-one derivatives and their use in therapy
06/17/2009EP2069323A1 Processes for the preparation of n-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)amino]sulfonyl}-2-thiophenecarboxamide
06/17/2009EP2069310A2 Sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists
06/17/2009EP1664046B1 Aza-quinolinol phosphonate integrase inhibitor compounds
06/17/2009CN101460508A Thiazolyl-dihydro-chinazoline
06/17/2009CN101460507A Thiazolyldihydroindazoles
06/17/2009CN101460506A Thiazolyldihydroindazole derivatives as protein kinase inhibitors
06/17/2009CN101460505A Thiazolyl-dihydroquinazolines
06/17/2009CN101456872A Thiazole[3,2-a] miazine derivates and use thereof
06/17/2009CN100500672C N1,N3-disubstituted thieno[3,2-e][2,1,3] thiadiazine-2,2,4-triones derivatives and use thereof
06/16/2009US7547786 Process for producing thiazole derivative
06/16/2009US7547782 Met kinase inhibitors
06/16/2009CA2361936C Formulations comprising imiquimod or other immune response modifiers for treating mucosal conditions
06/11/2009WO2009073777A1 Gamma secretase modulators
06/11/2009WO2009071895A1 Fused thiazole and thiophene derivatives as kinase inhibitors
06/11/2009WO2009071890A1 Tricyclic kinase inhibitors
06/11/2009WO2009071888A1 Pyrrolothiazoles as pi3-kinase inhibitors
06/11/2009WO2008135524A3 Substituted anthranilamides and analogues, manufacturing and use thereof as medicaments
06/11/2009WO2002030358A3 Modulation of ccr4 function
06/11/2009US20090149649 Aromatic hetrocyclic compound, organic light-emitting diode including organic layer comprising the aromatic hetrocyclic compound, and method of manufacturing the organic light-emitting diode
06/11/2009US20090149453 Methods and compositions for treating bacterial infections and diseases associated therewith
06/11/2009US20090149452 Xanthine oxidase inhibitor
06/11/2009CA2707712A1 Gamma secretase modulators
06/10/2009EP2066676A1 HETEROCYCLIC INHIBITORS OF c-MET AND USES THEREOF
06/10/2009EP1711499B1 Fused pyrrolocarbazoles and methods for the preparation thereof
06/10/2009EP1601673B1 Fused heterocycles and uses thereof
06/10/2009CN100496493C 2-amino-4, 5-trisubstituted thiazolyl derivatives
06/09/2009US7544806 Piperidine-substituted indoles-or heteroderivatives thereof
06/09/2009US7544701 Central nervous system disorders; psychological disorders
06/09/2009US7544697 Pyrazolopyridines and analogs thereof
06/09/2009US7544690 MCH receptor antagonists
06/04/2009WO2009070516A1 Imidazo-thiazole derivatives as protein kinase inhibitors
06/04/2009WO2009068467A1 Aminothiazole derivatives
06/04/2009WO2008087611A3 Pyrrolidine- and piperidine- bis-amide derivatives
06/04/2009US20090143376 Fused Heterocyclic Compounds and Their Use as Sirtuin Modulators
06/04/2009US20090142347 Tissue-Nonspecific Alkaline Phosphatase (TNAP): a Therapeutic Target for Arterial Calcification
06/04/2009CA2706574A1 Aminothiazole derivatives
06/04/2009CA2705906A1 Imidazo-thiazole derivatives as protein kinase inhibitors
06/03/2009EP2065389A1 Thiazole-based semiconductor compound and organic thin film transistor using the same
06/03/2009EP2065379A1 Benzimidazole compound having gastric acid secretion inhibitory activity
06/03/2009EP2064198A2 Substituted indanyl sulfonamide compounds, their preparation and use as medicaments
06/03/2009EP2064180A1 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections
06/03/2009EP1660077B1 Indol-6 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
06/03/2009EP1648446B1 Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
06/03/2009EP1648445B1 Indol-5-yl sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
06/03/2009EP1648444B1 Indol-7 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
06/03/2009CN101448844A Thiazolo-pyramidine / pyridine urea derivatives as adenosine a2b receptor antagonists
06/03/2009CN101448843A Imidazolothiazole compounds for the treatment of disease
06/02/2009US7541463 Lung cancer, gastric cancer, liver cancer, leucocythemia, endometrioma, oophoroma, mammary cancer, colon cancer, prostatic cancer, or pituitary gland cancer; N (N',N'-dimethylaminoethyl)benzo[b]thieno[2,1-c]naphthalimide
06/02/2009US7541367 3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
05/2009
05/28/2009WO2009067618A1 Substituted benzoazole pde4 inhibitors for treating pulmonary and cardiovascular disorders
05/28/2009WO2009067604A1 Substituted benzoazole pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders
05/28/2009WO2009038757A3 Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith
05/28/2009US20090137806 Dual nk1/nk3 receptor antagonists
05/28/2009US20090137597 Novel quinoxalinone derivatives
05/28/2009US20090137568 Tryclic Nitrogen Containing Compounds and their Use as Antibacterials
1 ... 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 ... 152